ArticleJournal of Korean Neurosurgical Society2013
Clinical analysis of intracranial hemangiopericytoma.
Article in Journal of Korean Neurosurgical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.Neurosurgical review · 2021Pooled it
- A rare case: solitary fibrous tumor with widespread metastasis on [European journal of nuclear medicine and molecular imaging · 2026Article
- A Case of Intracranial Solitary Fibrous Tumor Followed by Distant Metastasis without Local Recurrence.NMC case report journal · 2025Article
- Complete Resection of a Torcular Herophili Hemangiopericytoma without Sinus Reconstruction: A Case Report and Review of the Literature.Case reports in surgery · 2023Article
- Grade III solitary fibrous tumor/hemangiopericytoma: An enthralling intracranial tumor-A case report and literature review.Radiology case reports · 2022Article
- Deep Learning Model for Intracranial Hemangiopericytoma and Meningioma Classification.Frontiers in oncology · 2022Article
- Solitary Fibrous Tumor Revealed by Worsening Clinical Depression: A Case Report from Oman.Cureus · 2020Article
- Intracranial solitary fibrous tumor/hemangiopericytoma - A case series.Surgical neurology international · 2020Article
- The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor.Oncology reviews · 2018Article
- Occipital Falcine Anaplastic Hemangiopericytoma Mimicking Meningioma.Journal of neurosciences in rural practice · 2016Article
- Meningeal Solitary Fibrous Tumors with Delayed Extracranial Metastasis.Journal of pathology and translational medicine · 2016Article
- Treatment Strategy of Intracranial Hemangiopericytoma.Brain tumor research and treatment · 2015Article
- Intracranial Hemangiopericytomas : A Retrospective Study of 15 Patients with a Special Review of Recurrence.Journal of Korean Neurosurgical Society · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIntracranial hemangiopericytomas (HPCs) are rare tumors with aggressive behavior, including local recurrence and distant metastasis. We conducted this retrospective study to evaluate the efficacy of grossly total resection and adjuvant radiotherapy (RT) for these tumors.
methodsA total of 13 patients treated for intracranial HPC from January 1995 through May 2013 were included in this retrospective study. We analyzed the clinical presentations, radiologic appearances, treatment results, and follow-up outcomes, as well as reviewed other studies.
resultsThe ages of the patients at the time of diagnosis ranged from 26 to 73 years (mean : 48 years). The majority of the patients were male (92.3%), and the majority of the tumors were located in the parasagittal and falx. The ratio of intracranial HPCs to meningiomas was 13 : 598 in same period, or 2.2%. Seven patients (53.8%) had anaplastic HPCs. Nine patients (69.2%) underwent gross total tumor resection in the first operation without mortality. Eleven patients (84.6%) underwent postoperative adjuvant RT. Follow-up period ranged from 13 to 185 months (mean : 54.3 months). The local recurrence rate was 46.2% (6/13), and there were no distant metastases. The 10-year survival rate after initial surgery was 83.9%. The initial mean Karnofsky performance scale (KPS) was 70.8 and the final mean KPS was 64.6.
conclusionGross total tumor resection upon initial surgery is very important. We believe that adjuvant RT is helpful even with maximal tumor resection. Molecular biologic analyses and chemotherapy studies are required to achieve better outcomes in recurrent intracranial HPCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.